Old Web
English
Sign In
Acemap
>
authorDetail
>
Yiting Li
Yiting Li
Central South University
Medicine
Osimertinib
Cancer research
Lung cancer
T790M
3
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The novel MET inhibitor, HQP8361, possesses single agent activity and enhances therapeutic efficacy of AZD9291 (osimertinib) against AZD9291-resistant NSCLC cells with activated MET.
2020
American Journal of Cancer Research
Danlei Yu
Yiting Li
Keven Dy Sun
Jiajia Gu
Zhen Chen
Taofeek K. Owonikoko
Suresh S. Ramalingam
Shi-Yong Sun
Show All
Source
Cite
Save
Citations (5)
Label-free detection of miRNA cancer markers based on terminal deoxynucleotidyl transferase-induced copper nanoclusters
2019
Analytical Biochemistry
Yiting Li
Di-hong Tang
Li Zhu
Jingting Cai
Chaonan Chu
Jing Wang
Man Xia
Zhenzhen Cao
Hong Zhu
Show All
Source
Cite
Save
Citations (7)
ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib.
2019
Cancer
Yiting Li
Hongjing Zang
Guoqing Qian
Taofeek K. Owonikoko
Suresh R. Ramalingam
Shi-Yong Sun
Show All
Source
Cite
Save
Citations (19)
1